Abstract
Diabetes is a heterogeneous disease with three main types: type 1, type 2, and latent autoimmune diabetes. The main condition that develops in type 2 diabetes is insulin resistance. In type 1 diabetes and LADA, lack of insulin production is the primary condition but one should be aware that many of these patients also develop a resistance to exogenous insulin if they become obese. It is generally well understood that any weight loss or improved dietary management can help to control diabetes. However, when these attempts prove ineffective, bariatric surgery is considered. This chapter reviews the current role of the Sleeve Gastrectomy in the treatment of obesity related diabetes. Concepts reviewed include diabetes outcomes by BMI, duration of diabetes, time to resolution, C-peptide production, Pouch/Bougie size, and comparison to other procedures. The heterogeneity of diabetes and the variations in sleeve gastrectomy technique make it difficult to analyze outcomes but many reasonable conclusions can be made.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes and obesity-related health risk factors, 2001. JAMA. 2003;289(1):76–9.
Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222(3):339–50.
Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg. 1998;8(3):267–82.
Ren CJ. Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg. 2000;10(6):514–23. discussion 524.
Lee CM. Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results. Surg Endosc. 2007;21(10):1810–6.
Bellanger DE, Greenway FL. Laparoscopic sleeve gastrectomy, 529 cases without a leak: short term results and technical considerations. Obes Surg. 2011;21:146–50.
Mechanik JI, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Obesity. 2013;21:S1–27.
Langer FB, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;14:1024–9.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric Surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.
Brethauer A, Hammel JP, Schauer PR. Systematic review of sleeve gastrectomy as staging and primary bariatric procedure. Surg Obes Relat Dis. 2009;5(4):469–75.
Gill RS, Sharma AM, Al-Adra DP, et al. The impact of bariatric surgery in patients with Type-2 diabetes mellitus. Curr Diabetes Rev. 2011;7:185–9.
Silecchia G, Boru C, Pecchia A, et al. Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Obes Surg. 2006;16:1138–44.
Cottam D, Dureshi FG, Mattar SF, et al. Laparoscopic sleeve gastrectomy as an initial weight loss procedure for high-risk patients with morbid obesity. Surg Endosc. 2006;20:859–63.
Vidal J, Ibarzabal A, Romero F, et al. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg. 2008;18:1077–82.
Kehagias I, Spyropoulos C, Karamanakos S, et al. Efficacy of sleeve gastrectomy as sole procedure in patients with clinical severe obesity. Surg Obes Relat Dis. 2013;9(3):363–9.
Menenkakos E, Stamou K, Albanoupoulos K, et al. Laparoscopic sleeve gastrectomy performed with intent to treat morbid obesity: a prospective single-center study of 261 patients with a median follow-up of 1 year. Obes Surg. 2010;20:276–82.
Basso N, Casella G, Rizzello M. Laparoscopic sleeve gastrectomy as first stage or definitive intent in 300 consecutive cases. Surg Endosc. 2011;25:444–9.
Magee CJ, Barry J, Arumugasamy M. Laparoscopic sleeve gastrectomy for high-risk patients: weight loss and comorbidity improvement-short-term results. Obes Surg. 2011;21(5):547–50.
Abbatini F, Capoccia D, Basso N. Type 2 diabetes in obese patients with body mass index of 30-35 kg/m2: sleeve gastrectomy versus medical treatment. Surg Obes Relat Dis. 2012;8(1):20–4.
Atkins ER, Preen DB, Cohen LD. Improved obesity reduction and co-morbidity resolution in patients treated with 40 French bougie versus 50 French bougie four years after laparoscopic sleeve gastrectomy. Analysis of 294 patients. Obes Surg. 2012;22(1):97–104.
Spivak H, Moshe R, Sadot E. Laparoscopic sleeve gastrectomy using a 42-French versus a 32 French bougie: the first-year outcome. Obes Surg. 2014;24(7):1090–3.
Abdallah E, El Nakeeb A, Yousef T. Impact of extent of antral resection on surgical outcomes of sleeve gastrectomy for morbid obesity (A prospective randomized study). Obes Surg. 2014;24(10):1587–94.
Rizzello M, Abbatine F, Casella G. Early postoperative insulin-resistance changes after sleeve gastrectomy. Obes Surg. 2010;20(1):50–5.
Rosenthal R, Li X, Somstein S. Effect of sleeve gastrectomy on patients with diabetes mellitus. Surg Obes Relat Dis. 2009;5(4):429–34.
Casella G, Basso N. Ten-year duration of type 2 diabetes mellitus as a prognostic factor for remission after sleeve gastrectomy. Surg Obes Relat Dis. 2011;7:697–702.
Shah PS, Todkar JS, Shah SS. Effectiveness of laparoscopic sleeve gastrectomy on glycemic control in obese Indians with type 2 diabetes mellitus. Surg Obes Relat Dis. 2010;6(2):138–41.
Slater BJ, Bellatorre N, Eisenberg D. Early postoperative outcomes and medication cost savings after laparoscopic sleeve gastrectomy in morbidly obese patients with type 2 diabetes. J Obes. 2011;2011:350523.
Todkar JS, Shah SS, Shah PS, et al. Long-term effects of laparoscopic sleeve gastrectomy in morbidly obese subjects with type 2 diabetes mellitus. Surg Obes Relat Dis. 2010;6(2):142–5.
Vidal J, Ibarzabal A, Lacy A. Short term effects of sleeve gastrectomy on type 2 diabetes mellitus in severely obese subjects. Obes Surg. 2007;17:1069–74.
Bayham BE, Greenway FL, Bellanger DE, et al. Early resolution of type 2 diabetes seen after Roux en Y gastric bypass and vertical sleeve gastrectomy. Diabetes Technol Ther. 2012;14(1):30–4.
Pham S, Gancel A, Scotte M. Comparison of the effectiveness of four bariatric surgery procedures in obese patients with type 2 diabetes: a retrospective study. J Obes. 2014;2014:638203.
Yip S, Plank LD, Murphy R. Gastric bypass and sleeve gastrectomy for type 2 diabetes: a systematic review and meta-analysis of outcomes. Obes Surg. 2013;23:1994–2003.
Zhang C, Yuan Y, Qiu C, et al. A meta-analysis of 2-year effect after surgery: laparoscopic Roux en Y gastric bypass versus laparoscopic sleeve gastrectomy for morbid obesity and diabetes mellitus. Obes Surg. 2014;24:1528–35.
Zhang Y, Wang J, Sun X, et al. Laparoscopic sleeve gastrectomy versus laparoscopic Roux en Y gastric bypass for morbid obesity and related comorbidities: a meta-analysis of 21 studies. Obese Surg. 2015;25:19.
Lee WJ, Hur KY, Lakadawala M, et al. Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional intertnational study. J Gastrointest Surg. 2012;16:45–51.
Oman JJ, Nguyen SQ, Herron D. Comparison of comorbidity resolution and improvement between laparoscopic sleeve gastrectomy and laparoscopic adjustable gastric banding. Surg Endosc. 2010;24:2513–7.
Abbatini F, Rizzello M, Casella G. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc. 2010;24:1005–10.
Schauer PR, Bhatt DL, Kirwan J. Bariatric surgery versus intensive medical therapy for diabetes- 3 year outcomes. N Engl J Med. 2014;371(7):682.
Iannelli A, Schneck AS, Topart P. Laparoscopic sleeve gastrectomy followed by duodenal switch in selected patients versus single-stage duodenal switch for superobesity: case-control study. Surg Obes Relat Dis. 2013;9(4):531–8.
Prachand VN, Ward M, Alverdy JC. Duodenal switch provides superior resolution of metabolic comorbidities independent of weight loss in the super-obese (BMI > 50kg/m2) compared with gastric bypass. J Gastrointest Surg. 2010;14:211–20.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this chapter
Cite this chapter
Jossart, G.H. (2016). Sleeve Gastrectomy. In: Kurian, M., Wolfe, B., Ikramuddin, S. (eds) Metabolic Syndrome and Diabetes. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3220-7_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3220-7_12
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-3219-1
Online ISBN: 978-1-4939-3220-7
eBook Packages: MedicineMedicine (R0)